December 3, 2023: 

Bringing the best ideas forward, pulling expertise across cancer centers, connecting through mentorships, and ensuring racial, ethnic and gender diversity in clinical trial participation are critical components of the Big Ten Cancer Research Consortium (Big Ten CRC), according to Chief Scientific Officer Monika Joshi, MD, MRCP, from the Penn State Cancer Institute, who spoke at the Big Ten CRC Summit 2023, which brought together more than 110 researchers, investigators, cancer centers, and industry participants. Read More

September 1, 2023: 

The Big Ten Cancer Research Consortium Diversity Committee talks with investigators, industry sponsors and patient advocates on how to work together to develop policies and strategic priorities for the Big Ten CRC that will foster growth, learning, and change that will create a more equitable environment for patients enrolled in clinical trials. Episode one: “Conversation with the Co-Chairs” is now available on Spotify and Amazon Music! Read More

September 6, 2023:

The Big Ten Cancer Research Consortium’s annual summit is being held at Big Ten Conference Headquarters in Chicago. The summit will take place on Saturday, September 30, 2023, and is hosted by the University of Wisconsin Carbone Cancer Center. Read More

August 31, 2023:

Members of the population science clinical trial working group had their work published in Cancer Epidemiology, Biomarkers & Prevention. The article is titled, “Current Approaches to Serving Catchment Areas in Cancer Centers: Insights from the Big Ten Cancer Research Consortium Population Science Working Group.” Read More

May 26, 2023: 

Big Ten CRC lung cancer study to be presented at American Society of Clinical Oncology (ASCO) 2023 Annual Meeting in Chicago. Cynthia Wei, MD of the Indiana University School of Medicine will present on the Big Ten CRC study titled, “Phase II Study of Consolidation Immunotherapy with Nivolumab and Ipilimumab or Nivolumab alone following Concurrent Chemoradiotherapy for Unresectable Stage IIIA/IIIB Non-small Cell Lung Cancer (NSCLC).” Read More

May 1, 2023: 

Big Ten Cancer Research Consortium (Big Ten CRC) will have an exhibitors booth at the American Society of Clinical Oncology (ASCO) 2023 Annual Meeting. Visit Booth #28115 to talk with our highly qualified staff about managing oncology/hematology multi-center clinical trials. Read More

March 27, 2023: 

Results from a Big Ten CRC bladder cancer study of concurrent durvalumab and radiation therapy (DUART) followed by adjuvant durvalumab in patients with localized urothelial cancer of bladder were published in the Journal for ImmunoTherapy of Cancer. Sponsor-investigator Monika Joshi, MD, of Penn State Cancer Institute led this single-arm, multi-institutional phase II study.
Read More

February 15, 2023:

The University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC) has a long and distinguished history of advancing the field of cancer care. Among the Center’s significant advances are pioneering work into aromatase inhibitors and the development of GammaPod radiation therapy, both for breast cancer.

February 15, 2023:

Investigators of two Big Ten CRC studies presented their findings during the American Society of Clinical Oncology Genitourinary (GU) Cancers Symposium on February 16-18, 2023, in San Francisco, CA. Sara E. Fenton, MD, PhD of Northwestern University will present a Big Ten Cancer Research Consortium prostate cancer study and Yousef Zakharia of the Iowa Holden Comprehensive Cancer Center will present on a renal cell carcinoma study. 

Read More

November 12, 2022:

Cheryl L. Knott, PhD, is a Professor in the Department of Behavioral and Community Health, as well as Co-Leader of the Population Science Program and Associate Director of Community Outreach and Engagement at the University of Maryland Greenebaum Comprehensive Cancer Center. She is also Editor-in-Chief of the peer-reviewed journal, Translational Behavioral Medicine.